These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 27986834)
21. Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans serotype C as determined by 2D 1H NMR spectroscopy. Bacon BE; Cherniak R Carbohydr Res; 1995 Oct; 276(2):365-86. PubMed ID: 8542606 [TBL] [Abstract][Full Text] [Related]
22. Involvement of the capsular GalXM-induced IL-17 cytokine in the control of Cryptococcus neoformans infection. LaRocque-de-Freitas IF; Rocha JDB; Nunes MP; Oliveira PAV; Nascimento DO; Freire-de-Lima L; Takiya CM; Morrot A; Decote-Ricardo D; Previato JO; DosReis GA; Mendonça-Previato L; Freire-de-Lima CG Sci Rep; 2018 Nov; 8(1):16378. PubMed ID: 30401972 [TBL] [Abstract][Full Text] [Related]
23. Facile synthesis of the heptasaccharide repeating unit of O-deacetylated GXM of C. neoformans serotype B. Zhao W; Kong F Bioorg Med Chem; 2005 Jan; 13(1):121-30. PubMed ID: 15582457 [TBL] [Abstract][Full Text] [Related]
24. Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans. McFadden DC; Fries BC; Wang F; Casadevall A Eukaryot Cell; 2007 Aug; 6(8):1464-73. PubMed ID: 17601878 [TBL] [Abstract][Full Text] [Related]
25. Structure and immunoregulatory activity of β-d-galactofuranose-containing polysaccharides from the medicinal fungus Shiraia bambusicola. Zhou D; Li P; Dong Z; Wang T; Sun K; Zhao Y; Wang B; Chen Y Int J Biol Macromol; 2019 May; 129():530-537. PubMed ID: 30710588 [TBL] [Abstract][Full Text] [Related]
26. Type-specific polysaccharides of Cryptococcus neoformans. n.m.r.-spectral study of a glucuronomannan chemically derived from a Tremella mesenterica exopolysaccharide. Cherniak R; Jones RG; Slodki ME Carbohydr Res; 1988 Nov; 182(2):227-39. PubMed ID: 3072079 [TBL] [Abstract][Full Text] [Related]
27. Synthesis of oligosaccharides corresponding to structures found in capsular polysaccharides of Cryptococcus neoformans--II. Garegg PJ; Olsson L; Oscarson S Bioorg Med Chem; 1996 Nov; 4(11):1867-71. PubMed ID: 9007271 [TBL] [Abstract][Full Text] [Related]
28. Structure determination of Cryptococcus neoformans serotype A-variant glucuronoxylomannan by 13C-n.m.r. spectroscopy. Cherniak R; Jones RG; Reiss E Carbohydr Res; 1988 Jan; 172(1):113-38. PubMed ID: 3280130 [TBL] [Abstract][Full Text] [Related]
30. Synthesis of a heptasaccharide fragment of the O-deacetylated GXM of C. neoformans serotype C. Zhao W; Kong F Carbohydr Res; 2005 Jul; 340(10):1673-81. PubMed ID: 15927170 [TBL] [Abstract][Full Text] [Related]
31. Bioactive Exopolysaccharides Reveal Dong Z; Liu W; Zhou D; Li P; Wang T; Sun K; Zhao Y; Wang J; Wang B; Chen Y Molecules; 2019 May; 24(11):. PubMed ID: 31146421 [No Abstract] [Full Text] [Related]
32. Cryptococcus neoformans galactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy. Vecchiarelli A; Pericolini E; Gabrielli E; Chow SK; Bistoni F; Cenci E; Casadevall A Immunotherapy; 2011 Aug; 3(8):997-1005. PubMed ID: 21843086 [TBL] [Abstract][Full Text] [Related]
33. Parallel beta-helix proteins required for accurate capsule polysaccharide synthesis and virulence in the yeast Cryptococcus neoformans. Liu OW; Kelly MJ; Chow ED; Madhani HD Eukaryot Cell; 2007 Apr; 6(4):630-40. PubMed ID: 17337638 [TBL] [Abstract][Full Text] [Related]
34. Synthesis of a hexasaccharide fragment of the O-deacetylated GXM of C. neoformans serotype B. Zhao W; Kong F Carbohydr Res; 2004 Jul; 339(10):1779-86. PubMed ID: 15220088 [TBL] [Abstract][Full Text] [Related]
35. Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network. Cherniak R; Valafar H; Morris LC; Valafar F Clin Diagn Lab Immunol; 1998 Mar; 5(2):146-59. PubMed ID: 9521136 [TBL] [Abstract][Full Text] [Related]
36. Anti-chemotactic activity of capsular polysaccharide of Cryptococcus neoformans in vitro. Fujihara H; Kagaya K; Fukazawa Y Microbiol Immunol; 1997; 41(9):657-64. PubMed ID: 9343815 [TBL] [Abstract][Full Text] [Related]
37. Structure and immunostimulating activity of a galactofuranose-rich polysaccharide from the bamboo parasite medicinal fungus Shiraia bambusicola. Wang T; Dong Z; Zhou D; Sun K; Zhao Y; Wang B; Chen Y J Ethnopharmacol; 2020 Jul; 257():112833. PubMed ID: 32289476 [TBL] [Abstract][Full Text] [Related]
38. The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. Kozel TR; Gotschlich EC J Immunol; 1982 Oct; 129(4):1675-80. PubMed ID: 7050244 [TBL] [Abstract][Full Text] [Related]
39. Identification of a putative α-galactoside β-(1 → 3)-galactosyltransferase involved in the biosynthesis of galactomannan side chain of glucuronoxylomannogalactan in Kadooka C; Tanaka Y; Hira D; Oka T Front Microbiol; 2024; 15():1390371. PubMed ID: 38841067 [TBL] [Abstract][Full Text] [Related]
40. Assimilation of xylose, mannose, and mannitol for synthesis of glucuronoxylomannan of Cryptococcus neoformans determined by 13C nuclear magnetic resonance spectroscopy. Cherniak R; O'Neill EB; Sheng S Infect Immun; 1998 Jun; 66(6):2996-8. PubMed ID: 9596780 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]